[
    {
        "utterance": "Emily Balskus: Yeah, would anyone like to start with an introduction? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah, I I will start. So this is Kaixiong Ye and I'm at the University of Georgia. I'm working on human genetics. I analyze big genetic and phenotypic data set. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Faranak Fattahi: I'll go next. Um, my name is Faranak Fattahi. I'm from UCSF. Uh, so my work is mostly focused on using stem cells, IPSCs and embryonic stem cells to make organoid models, in vitro models of primarily the anterior nervous system, but also other components of the GI tract. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Maybe maybe we should just call on people. Lisa, you want to go next? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Imposing Structure",
                    "definition": "The speaker introduces a more rigid or controlled method for interaction, potentially limiting the organic flow or self-organization of the group.",
                    "justification": "The speaker explicitly suggests and implements a shift from voluntary participation to a directed approach for introductions, stating, \"Maybe maybe we should just call on people. Lisa, you want to go next? .\" This imposes a specific order rather than allowing participants to self-select, which can hinder emergent collaboration."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Ryno: Sure. I'm Lisa Rhino. I'm an assistant professor in the chemistry and biochemistry department at Oberlin College. Um, I study um stress responses in bacteria and as an application to look at um biofilm formation. Um, also um using those stress responses as sensors for um sub inhibitory concentrations of antibiotics in water. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Good. I'm I'm George Weinstock by the way. I'm a facilitator and uh I'm at Jackson Laboratory. I'm a sort of microbiome genomics kind of guy. Um, Tanya. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tanya Nguyen: Hi everyone. I'm Tanya Gwen. I'm an assistant professor of psychiatry at UC San Diego. I'm a neuropsychologist. I do clinical research and um my focus is on biomarkers of accelerated aging including the microbiome in serious mental illnesses like schizophrenia and bipolar disorder. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tanya Nguyen: And I'm really interested in understanding microbial metabolite interactions in schizophrenia and how they contribute to cognitive impairment and uh cardio cardio metabolic dysfunction. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Great, thank you. Emily, you want to introduce yourself? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, so I'm Emily Balskus. I'm a professor in the Department of Chemistry and Chemical Biology at Harvard. Um, a facilitator here and my lab studies gut microbial metabolic activities and enzymes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Robin. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Robin Michelle Voigt-Zuwala: Um, I'm an associate professor at Rush University Medical Center in Chicago and I primarily study how modifiable lifestyle factors like diet, exercise, sleep, circadian rhythms impact the microbiome and the effect on a number of different diseases. Um, primarily right now Alzheimer's, Parkinson's disease and PTSD. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Great. Tom. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Tom Mansell, I'm uh from Iowa State. I'm in chemical engineering and uh my area is engineering bacteria. Uh our goal is to build live biotherapeutics and so we use prebiotics and uh engineered probiotics to uh uh the goal is to secrete therapeutic small molecules, peptides and proteins uh in situ in the gut. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Good. Camille. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Camille Nebeker: Hi everyone. I'm Camille Nebeker. I'm in the School of Public Health at UC San Diego. My training is in behavioral medicine and public health. Um, the work that I'm doing is is as a research ethicist, bioethicist looking at emerging novel technologies, um primarily digital health, artificial intelligence and how to do this work ethically and responsibly. And Tanya and I also collaborate on an AI and healthy aging project. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Camille Nebeker: So FYI we can't be on the same project. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Stating collaboration constraints",
                    "definition": "The speaker explicitly states a pre-existing condition or rule that limits their ability to collaborate with certain individuals or on certain types of projects, potentially narrowing the scope of team formation.",
                    "justification": "The speaker explicitly states a limitation on collaboration, which could hinder team formation, as evidenced by the quote 'we can't be on the same project.'"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Okay, thanks. Chris. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Chris Whidbey: Hi, I'm Chris Whidbey. I'm an assistant professor at Seattle University in the chemistry department. Um, my group uses chemical biology tools, so um different omics techniques, activity based protein profiling to study microbial metabolism especially related to maternal child health. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Okay, Jay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Hi everybody. I'm Jay Song from the Mayo Clinic. I'm a computational biologist um and bioinformatician here. Um, our lab uh focuses on um basically has two branches. One is more on the clinical and translational side where we analyze a bunch of uh different types of omics data ranging from microbiome, metabolomics, immune phenotyping, antibody profiles, proteomics. So really get a a global understanding of um of uh patients with autoimmune disease, uh rheumatoid arthritis and vasculitis in particular and basically try to find biomarkers for prognostics and diagnostics. Um, on more of the kind of like the computational biologist/ basic science side, we're interested in um uh chemical ecology and also uh looking at uh different types of um uh small molecules that microbes can create but as a community rather than focusing on one bug at a time. And we're trying to link those two together being like, okay, what molecules can these kind of particular gut microbiome influence the onset or, you know, mediation of autoimmune uh disease. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly detailed self-introduction",
                    "definition": "The speaker provides an extensive and highly specific description of their background, research, or lab, which may be excessive for an initial introduction in a collaborative setting.",
                    "justification": "The speaker offers a very lengthy and granular overview of their lab's two research branches, enumerating various omics data types, specific autoimmune diseases, and detailed interests in chemical ecology and microbial small molecules. This extensive detail, exemplified by \"Um, our lab uh focuses on um basically has two branches. One is more on the clinical and translational side where we analyze a bunch of uh different types of omics data ranging from microbiome, metabolomics, immune phenotyping, antibody profiles, proteomics... Um, on more of the kind of like the computational biologist/ basic science side, we're interested in um uh chemical ecology and also uh looking at uh different types of um uh small molecules that microbes can create...\", could overwhelm listeners and make it harder to quickly identify broad collaborative opportunities in a time-constrained introductory round."
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Okay, great, thank you. Um, Joan, do you want to tell us a little bit about yourself? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Joan Woodard: Yeah, thanks George. Let's see. So I am a member of the Board of Directors of RCSA. So I'm here just as an observer and I some years in the past I attended in person one of the silogs, but it's been a while and so I thought I would connect and just observe. So I appreciate you all and um I'm fascinated to hear what you uh develop here and ideas. Thanks. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Declares observer status",
                    "definition": "The speaker explicitly states their role is to observe rather than actively participate in the collaborative discussion or team formation.",
                    "justification": "The speaker clearly indicates they are not an active participant in the meeting's core purpose, stating, \"I'm here just as an observer and I some years in the past I attended in person one of the silogs, but it's been a while and so I thought I would connect and just observe.\" This explicitly signals non-engagement in the collaborative task."
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Okay, and then um, Bot five can remain anonymous and uh how about Elizabeth? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Weiss: Hi everyone, I'm Elizabeth Weiss. Um, I'm with the Science Philanthropy Alliance. Uh, we work with funders in the space. So I'm I'm just here as an observer, but thank you for including me and I look forward to kind of seeing what everyone puts together. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Declares Non-Participant Role",
                    "definition": "The speaker explicitly states their role is not to actively participate in the scientific discussion or team formation, but rather to observe. This behavior indicates they are not a potential collaborator for grant proposals.",
                    "justification": "The speaker explicitly states, \"I'm just here as an observer,\" signaling that they will not be engaging as a potential team member or contributor to the scientific ideas being discussed for grant proposals."
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Okay. Is is there anybody that uh we didn't call on? Okay, good. We're going. Um, Emily, you want to uh, you know, give those bullet points and maybe get us going? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Sure. So um, yeah, so I think Jay has the slide up. The the things that we're supposed to be thinking about in this session are um, microbial fermentation products. So the microbiome obviously generates a lot of metabolic end products and and some of which have uh been well characterized to have um, you know, important functions uh and influence the host. You know, how are these uh species related um to neurological disorders? Uh, is the connection direct uh or or indirect? Um, try to think if there's any more uh yeah, so that that kind of covers covers what we're we're tasked with uh thinking about. Um, you know, what are the roles of these these molecules? What are the important molecules? How are they working? And yeah, George, do we want to start by having everybody just like kind of take that minute to think about the discussion topics before opening it up? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Deferring Initiative",
                    "definition": "The speaker avoids taking direct action or making a decision, instead passing the responsibility or decision-making to another participant, even when prompted to lead.",
                    "justification": "Emily was asked to 'get us going' by George, but instead of directly initiating the discussion, she defers the decision on how to proceed back to George, suggesting a preparatory step rather than immediate engagement. \"And yeah, George, do we want to start by having everybody just like kind of take that minute to think about the discussion topics before opening it up?\""
                }
            ]
        }
    },
    {
        "utterance": "George Weinstock: Sounds good, sounds good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    }
]